Koyfin Home > Directory > Health Care > Arena Pharmaceuticals > Levered Free Cash Flow (FCF)

Arena Pharmaceuticals Levered Free Cash Flow (FCF) Chart (ARNA)

Arena Pharmaceuticals annual/quarterly Levered Free Cash Flow (FCF) from 2000 to 2018.
  • Arena Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-18m a 99.28% decrease of -18m year over year
  • Arena Pharmaceuticals Levered Free Cash Flow (FCF) for the last 12 months ending September 09, 2018 was $-88m a 55.90% decrease of -49m year over year
  • Arena Pharmaceuticals Annual Levered Free Cash Flow (FCF) for 2017 was $-39m a 140.39% decrease of -54m from 2016
  • Arena Pharmaceuticals Annual Levered Free Cash Flow (FCF) for 2016 was $16m a 517.72% increase of 81m from 2015
  • Arena Pharmaceuticals Annual Levered Free Cash Flow (FCF) for 2015 was $-65m a 34.14% decrease of -22m from 2014
Other Cash Flow Metrics:
  • Arena Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-31m a 40.98% decrease of -13m year over year
  • Arena Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $4m a -330.00% decrease of -12m year over year
View Chart On Koyfin

Quarterly ARNA Levered Free Cash Flow (FCF) Data

09/2018$-18m
06/2018$-26m
03/2018$-32m
09/2017$0m
06/2017$-17m
03/2017$-9m
09/2016$-12m
06/2016$0m
03/2016$-10m
12/2015$2m

Annual ARNA Levered Free Cash Flow (FCF) Data

2017$-39m
2016$16m
2015$-65m
2014$-43m
2013$27m
2012$-24m
2011$-41m
2010$-61m
2009$-101m
2008$-127m